Paper26464797
Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
Wang Q and 2 others. Transl Neurodegener, 2015. Cited by 708 papers, by iCite.
Cite this record
ConductScience Library. Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Papers, record 26464797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26464797
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References125
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11478935 | Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. | Brain Res | 2001 | https://conductscience.org/library/papers/11478935 | PubMed |
| 2 | 15313429 | Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. | Int Immunopharmacol | 2004 | https://conductscience.org/library/papers/15313429 | PubMed |
| 3 | 20308684 | Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. | Neurology | 2010 | https://conductscience.org/library/papers/20308684 | PubMed |
| 4 | 10802035 | Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. | Brain Res | 2000 | https://conductscience.org/library/papers/10802035 | PubMed |
| 5 | 22053982 | CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. | J Neuroinflammation | 2011 | https://conductscience.org/library/papers/22053982 | PubMed |
| 6 | 23077045 | The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. | J Neurosci | 2012 | https://conductscience.org/library/papers/23077045 | PubMed |
| 7 | 18167537 | Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. | PLoS One | 2008 | https://conductscience.org/library/papers/18167537 | PubMed |
| 8 | 23244239 | PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation. | J Neuroinflammation | 2012 | https://conductscience.org/library/papers/23244239 | PubMed |
| 9 | 25560322 | Helicobacter pylori infection is associated with worse severity of Parkinson's disease. | Parkinsonism Relat Disord | 2015 | https://conductscience.org/library/papers/25560322 | PubMed |
| 10 | 20303880 | Mechanisms underlying inflammation in neurodegeneration. | Cell | 2010 | https://conductscience.org/library/papers/20303880 | PubMed |
| 11 | 15285796 | Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. | J Neuroinflammation | 2004 | https://conductscience.org/library/papers/15285796 | PubMed |
| 12 | 23585721 | PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices. | Exp Neurobiol | 2013 | https://conductscience.org/library/papers/23585721 | PubMed |
| 13 | 7823959 | Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7823959 | PubMed |
| 14 | 25134730 | Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. | Neurobiol Dis | 2014 | https://conductscience.org/library/papers/25134730 | PubMed |
| 15 | 21295135 | Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. | Free Radic Biol Med | 2011 | https://conductscience.org/library/papers/21295135 | PubMed |
| 16 | 11099416 | Down-regulation of the macrophage lineage through interaction with OX2 (CD200). | Science | 2000 | https://conductscience.org/library/papers/11099416 | PubMed |
| 17 | 17116747 | A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. | FASEB J | 2007 | https://conductscience.org/library/papers/17116747 | PubMed |
| 18 | 16712818 | Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. | Brain Res | 2006 | https://conductscience.org/library/papers/16712818 | PubMed |
| 19 | 20409326 | Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. | Mol Brain | 2010 | https://conductscience.org/library/papers/20409326 | PubMed |
| 20 | 21858193 | Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. | PLoS One | 2011 | https://conductscience.org/library/papers/21858193 | PubMed |
Cited by499
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 708 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42911300 | MiR‑204‑5p modulates glial morphology and apomorphine‑induced rotational asymmetry without dopaminergic neuroprotection in a preclinical mouse model of Parkinson's disease. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42911300 | PubMed |
| 42884597 | Gut Microbiome-Mediated Neuroprotective Effect of the Mediterranean Diet: A Narrative Review of Cognitive Aging, Alzheimer's Disease, and Parkinson's Disease. | Nutrients | 2026 | https://conductscience.org/library/papers/42884597 | PubMed |
| 42865000 | Ageing, women's health and personalised medicine: Advancing artificial intelligence and therapeutics through the blueprint theory paradigm. | Exp Physiol | 2026 | https://conductscience.org/library/papers/42865000 | PubMed |
| 42820044 | Peripheral HMGB1 Downregulation Is Associated With the S100-IL-17 Axis in Parkinson's Disease: An Integrated Bulk and Single-Cell Transcriptomic Analysis. | Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42820044 | PubMed |
| 42794516 | Mitochondrial Quality Control Imbalance in the Heterogeneity of Parkinson's Disease: From Selective Vulnerability to Stratified Transformation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794516 | PubMed |
| 42775310 | Pramipexole enhances levodopa's therapeutic efficacy in Parkinson's disease: Role of glutaredoxin-1 (GRX1), peroxiredoxin3 (PRX3), thioredoxin (TRX), 8-hydroxy-2 -deoxyguanosine (8-OHDG), and neurosteroid dehydroepiandrosterone sulfate (DHEA-S). | J Med Biochem | 2026 | https://conductscience.org/library/papers/42775310 | PubMed |
| 42662738 | Self-Emulsifying Formulation of Huperzia carinata Extract to Improve Huperzine A Solubility for Therapeutic Efficacy Enhancement in Parkinsonian Mice. | ACS Omega | 2026 | https://conductscience.org/library/papers/42662738 | PubMed |
| 42653437 | Alkaloids as Emerging Neuroprotective Agents for Neurodegenerative Disorders: Insights into Tryptanthrin and Its Derivatives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653437 | PubMed |
| 42618838 | Dual-Pathway Astrocyte Failure in Parkinson's Disease: Therapeutic Targeting of Nrf2/TFEB Suppression and cGAS-STING/Ferroptosis Activation. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42618838 | PubMed |
| 42613627 | Advances in the clinical application of mesenchymal stem cells for neurological disorders. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42613627 | PubMed |
| 42599178 | Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β. | J Zhejiang Univ Sci B | 2026 | https://conductscience.org/library/papers/42599178 | PubMed |
| 42522048 | Neuroinflammation in Alzheimer's and Parkinson's diseases: pathogenic mechanisms and therapeutic strategies. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42522048 | PubMed |
| 42470577 | Intranasal 6-OHDA Induces TRPM3-mediated Neuroinflammation in the pVTA: A Preclinical Early-stage Parkinson's Disease Model. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42470577 | PubMed |
| 42470302 | Chemically Programmed Prodrug Nanoparticles for Precise Oral Dopamine Delivery to Deep Brain Regions in Parkinson's Disease. | Adv Mater | 2026 | https://conductscience.org/library/papers/42470302 | PubMed |
| 42450338 | Rewiring Lipid Metabolism: PINK1 as a Central Regulator of Mitochondrial Homeostasis in Parkinson's Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450338 | PubMed |
| 42360639 | The Diagnostic and Therapeutic Value of Micro-RNA in Parkinson's Disease. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42360639 | PubMed |
| 42355533 | Dysregulation of the Extracellular Matrix in the Synaptic Pathology of Parkinson's Disease: Molecular Mechanisms and Novel Therapeutic Approaches. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42355533 | PubMed |
| 42280341 | The Role of Polyphenols on Cognitive Function and Dementia Through Gut-Microbiota-Brain Axis Modulation: A Narrative Review. | Nutrients | 2026 | https://conductscience.org/library/papers/42280341 | PubMed |
| 42270967 | The Synthesis and Biological Activity of Series of New Polyfunctional Pyrroles with the Potential to Modulate Neuronal Viability. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42270967 | PubMed |
| 42263400 | The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42263400 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRYAB | 1410 | PubTator's text mining | https://conductscience.org/library/genes/1410 | NCBI Gene |
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| KDM6B | 23135 | PubTator's text mining | https://conductscience.org/library/genes/23135 | NCBI Gene |
| PARK7 | 11315 | PubTator's text mining | https://conductscience.org/library/genes/11315 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26464797
GET https://conductscience.org/api/papers/v1/26464797/references?page=2